Contribution of type 1 reactions to sensory and motor function loss in borderline leprosy patients and the efficacy of treatment with prednisone

International Journal of Leprosy

Volumn 66, Issue 3, 1998, Pages 340-347

  Roche, Paul W ^a   Theuvenet, Wim J ^a,c   Le Master, Joseph W ^b   Butlin, C Ruth ^a  

^a Anandaban Leprosy Hospital   (Nepal)

^b United Mission to Nepal   (Nepal)

^c NONE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PREDNISONE;

ADOLESCENT; ADULT; AGED; ARTICLE; BORDERLINE LEPROSY; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; NERVE FUNCTION; NERVE INJURY; PHYSICAL DISABILITY; SCHOOL CHILD; SCORING SYSTEM; SENSORY DYSFUNCTION; STEROID THERAPY; VOLUNTARY MOVEMENT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTI-INFLAMMATORY AGENTS; CHILD; COHORT STUDIES; DISABILITY EVALUATION; FEMALE; HUMANS; LEPROSY, BORDERLINE; MALE; MIDDLE AGED; MOTOR NEURONS; NEURONS, AFFERENT; PREDNISOLONE; RETROSPECTIVE STUDIES;

EID: 0032411359     PISSN: 0148916X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. ANON. Setting priorities. Int. J. Lepr. 64 Suppl. (1996) S91-S92.
2. BECN-BLEUMINK, M. and BERHE, D. Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy: experience in the leprosy control program of ALERT in Ethiopia Int. J Lepr. 60 (1992) 173-184.
3. BRANDSMA, W Nerve function assessment in leprosy patients Lepr. Rev. 52 (1981) 161-170.
4. JOB, C K. Nerve damage in leprosy. Int. J. Lepr. 57 (1989) 532-539.
5. KIRAN, K. U., STANLEY, J. N. A. and PEARSON, J. M H. the outpatient treatment of nerve damage in patients with borderline leprosy using a semi-standardised steroid regimen. Lepr. Rev. 56 (1985) 127-134.
6. LOCKWOOD, D. N. J., VINAYAKUMAR, S., STANLEY, J. N. A., MCADAM, K. P. W. J. and COLSTON, M. J. Clinical features and outcome of reversal (type 1) reactions in Hyderabad, India. Int. J. Lepr. 61 (1993) 8-15.
7. NAAFS, B. Treatment of reactions and nerve damage. Int. J. Lepr. 64 Suppl. (1996) S21-S28.
8. NAAFS, B., PEARSON, J. M. H. and WHEATE, H. W. Reversal reaction: the prevention of permanent nerve damage; comparison of short- and long-term steroid treatment. Int. J. Lepr. 47 (1979) 7-12.
9. RIDLEY, D. S. and JOPLING, W. H. Classification of leprosy according to immunity; a five-group system. Int. J. Lepr. 34 (1966) 255-273.
10. ROCHE, P. W., LE MASTER, J. W. and BUTLIN, C. R. Risk factors for type 1 reactions in leprosy. Int. J. Lepr. 65 (1997) 450-455.
11. VAN BRAKEL, W. H. Ph.D. thesis, University of Utrecht, 1994.
12. WATSON, J. M. Essential action to minimise disability in leprosy patients. London: The Leprosy Mission, 1986.
13. WHO EXPERT COMMITTEE ON LEPROSY. Fifth Report. Geneva: World Health Organization, 1977. Tech. Rep. Ser. 607.